Israel vs North Macedonia: The number of people with susceptibility test result for rifampicin
Israel
103
in 2021
North Macedonia
100
in 2021
Israel rank
108th
North Macedonia rank
109th
The number of people with susceptibility test result for rifampicin over time
- Israel
- North Macedonia
How they compare
Israel currently reports 103 against 100 in North Macedonia, a difference of 3.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was North Macedonia ahead.
Israel ranks 108th and North Macedonia ranks 109th of 155 countries.
Across the 2 decades both report, Israel averaged higher in 1 and North Macedonia in 1.
Head to head by decade
| Decade | Israel | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 129.33 | 130 | 0.6667 | North Macedonia |
| 2020s | 96 | 90.5 | 5.5 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Israel or North Macedonia?
- Israel, at 103 against 100 in North Macedonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Israel and North Macedonia?
- 3, with Israel ahead.
- How many years of comparable data are there for Israel and North Macedonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Israel and North Macedonia rank globally for the number of people with susceptibility test result for rifampicin?
- Israel ranks 108th and North Macedonia ranks 109th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.